Literature DB >> 22391517

Depressive episode characteristics and subsequent recurrence risk.

Scott B Patten1, Jeanne V A Williams, Dina H Lavorato, Andrew G M Bulloch, Glenda MacQueen.   

Abstract

BACKGROUND: Clinical practice guidelines increasingly recognize the heterogeneity associated with major depressive episodes (MDE), e.g. through strategies such as watchful waiting. However, the implications of episode heterogeneity for long-term prognosis have not been adequately explored.
METHODS: In this project, we used data from a Canadian longitudinal study to evaluate recurrence risks for MDE after an initial episode in the mid-1990s. This study collected data from a community cohort between 1994/1995 and 2008/2009 using biannual interviews. Characteristics of the index episode: syndromal versus sub-syndromal, duration of symptoms, and indicators of seriousness (activity restriction, high distress or suicidal ideation) were recorded. The ability of these variables to predict MDE recurrence was explored using proportional hazards modeling. Additional analyses using generalized estimating equations were used to assess robustness.
RESULTS: Even brief, sub-syndromal episodes not characterized by indicators of seriousness were associated with an increased risk of subsequent MDE. However, episodes meeting diagnostic criteria for MDE, those lasting longer than four weeks and those associated with indicators of seriousness were associated with much higher recurrence risk. Sub-syndromal episodes associated with these characteristics generally predicted subsequent MDE as strongly as the occurrence of MDE itself. LIMITATIONS: The data source did not include assessment of all potentially relevant covariates. The assessment of MDE used an abbreviated instrument.
CONCLUSIONS: Brief sub-syndromal episodes of depression are not usually targets of acute treatment, but such episodes have implications for subsequent MDE risk. Episode characteristics identify a range of outcomes that have potential implications for long-term management.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22391517     DOI: 10.1016/j.jad.2012.02.006

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  9 in total

1.  A comprehensive model of predictors of persistence and recurrence in adults with major depression: Results from a national 3-year prospective study.

Authors:  Nicolas Hoertel; Carlos Blanco; Maria A Oquendo; Melanie M Wall; Mark Olfson; Bruno Falissard; Silvia Franco; Hugo Peyre; Cédric Lemogne; Frédéric Limosin
Journal:  J Psychiatr Res       Date:  2017-07-22       Impact factor: 4.791

2.  Outcomes of Online Mindfulness-Based Cognitive Therapy for Patients With Residual Depressive Symptoms: A Randomized Clinical Trial.

Authors:  Zindel V Segal; Sona Dimidjian; Arne Beck; Jennifer M Boggs; Rachel Vanderkruik; Christina A Metcalf; Robert Gallop; Jennifer N Felder; Joseph Levy
Journal:  JAMA Psychiatry       Date:  2020-06-01       Impact factor: 21.596

3.  The sex-dependent role of the glucocorticoid receptor in depression: variations in the NR3C1 gene are associated with major depressive disorder in women but not in men.

Authors:  Nina Sarubin; Sven Hilbert; Felix Naumann; Peter Zill; Anna-Maria Wimmer; Caroline Nothdurfter; Rainer Rupprecht; Thomas C Baghai; Markus Bühner; Cornelius Schüle
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-08-22       Impact factor: 5.270

4.  Association between severity of depressive symptoms and chronic knee pain in Korean adults aged over 50 years: a cross-sectional study using nationally representative data.

Authors:  Su-Bin Han; Sook-Hyun Lee; In-Hyuk Ha; Eun-Jung Kim
Journal:  BMJ Open       Date:  2019-12-18       Impact factor: 2.692

5.  Major depression epidemiology from a diathesis-stress conceptualization.

Authors:  Scott B Patten
Journal:  BMC Psychiatry       Date:  2013-01-11       Impact factor: 3.630

6.  Pain, not chronic disease, is associated with the recurrence of depressive and anxiety disorders.

Authors:  Marloes M J G Gerrits; Patricia van Oppen; Stephanie S Leone; Harm W J van Marwijk; Henriëtte E van der Horst; Brenda W Penninx
Journal:  BMC Psychiatry       Date:  2014-06-25       Impact factor: 3.630

7.  Development and validation of a prediction algorithm for use by health professionals in prediction of recurrence of major depression.

Authors:  Jian Li Wang; Scott Patten; Jitender Sareen; James Bolton; Norbert Schmitz; Glenda MacQueen
Journal:  Depress Anxiety       Date:  2014-05       Impact factor: 6.505

8.  Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Graham Mazereeuw; Nathan Herrmann; Paul I Oh; David W L Ma; Cheng Tao Wang; Alexander Kiss; Krista L Lanctôt
Journal:  J Clin Psychopharmacol       Date:  2016-10       Impact factor: 3.153

9.  Pre-treatment EEG signal variability is associated with treatment success in depression.

Authors:  Natalia Jaworska; Hongye Wang; Dylan M Smith; Pierre Blier; Verner Knott; Andrea B Protzner
Journal:  Neuroimage Clin       Date:  2017-10-31       Impact factor: 4.881

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.